Intellipharmaceutics Intl. Inc. (IPCIF)

[wimuskyfisherman]

TREND- Odidi and company have certainly failed on monetizing their ANDA pipeline. They should just sell it off. I am guessing these items have been removed from the website as they are trying to reinvent themselves as a cannabis company and removed the evidence of past failure. Odidi and company have no market vision. They just copy what is already being done. And their copy attempts are not executed fast enough to actually profit. Heaven knows what they are working on in the cannabis realm. But it is already a crowded space. And as far as I know, most cannabis benefits are anecdotal at best. The only FDA approved drug in this space is for seizures. For once I would like to see Odidi at the front of something innovative. But so far, just me too stuff. The three I's... First come the Innovators, then the Imitators and then the Idiots... I would have to say Odidi falls between Imitator and Idiot.